Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
01 1Evonik Corporation
02 1MSN Laboratories Private Limited
03 1Shionogi Pharma Co., Ltd.
01 1Baloxavir Marboxil
02 2Baloxavir marboxil
01 1Germany
02 1India
03 1Japan
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
NDC Package Code : 62128-0394
Start Marketing Date : 2021-12-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0109
Start Marketing Date : 2022-03-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53044-004
Start Marketing Date : 2018-12-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Baloxavir Marboxil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baloxavir Marboxil, including repackagers and relabelers. The FDA regulates Baloxavir Marboxil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baloxavir Marboxil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Baloxavir Marboxil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Baloxavir Marboxil supplier is an individual or a company that provides Baloxavir Marboxil active pharmaceutical ingredient (API) or Baloxavir Marboxil finished formulations upon request. The Baloxavir Marboxil suppliers may include Baloxavir Marboxil API manufacturers, exporters, distributors and traders.
click here to find a list of Baloxavir Marboxil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Baloxavir Marboxil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Baloxavir Marboxil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Baloxavir Marboxil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Baloxavir Marboxil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Baloxavir Marboxil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Baloxavir Marboxil suppliers with NDC on PharmaCompass.
We have 3 companies offering Baloxavir Marboxil
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
